866-997-4948(US-Canada Toll Free)

United States Antibody-drug Conjugates Market Report 2017

Published By :

QYResearch

Published Date : Aug 2017

Category :

Pharmaceutical

No. of Pages : 103 Pages

In this report, the United States Antibody-drug Conjugates market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Antibody-drug Conjugates in these regions, from 2012 to 2022 (forecast).

United States Antibody-drug Conjugates market competition by top manufacturers/players, with Antibody-drug Conjugates sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
F. Hoffmann-La Roche
Seattle Genetics
Takeda Pharmaceuticals
AbbVie
AbGenomics
ADC Therapeutics
Agensys
ALMAC Group
Ambrx
Astellas Pharma

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
Seattle Genetics technology
ImmunoGen technology
Immunomedics technology
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Antibody-drug Conjugates for each application, including
IgG1 antibodies
HER2 antibodies

Table of Contents

United States Antibody-drug Conjugates Market Report 2017
1 Antibody-drug Conjugates Overview
1.1 Product Overview and Scope of Antibody-drug Conjugates
1.2 Classification of Antibody-drug Conjugates by Product Category
1.2.1 United States Antibody-drug Conjugates Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Antibody-drug Conjugates Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Seattle Genetics technology
1.2.4 ImmunoGen technology
1.2.5 Immunomedics technology
1.3 United States Antibody-drug Conjugates Market by Application/End Users
1.3.1 United States Antibody-drug Conjugates Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 IgG1 antibodies
1.3.3 HER2 antibodies
1.4 United States Antibody-drug Conjugates Market by Region
1.4.1 United States Antibody-drug Conjugates Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Antibody-drug Conjugates Status and Prospect (2012-2022)
1.4.3 Southwest Antibody-drug Conjugates Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Antibody-drug Conjugates Status and Prospect (2012-2022)
1.4.5 New England Antibody-drug Conjugates Status and Prospect (2012-2022)
1.4.6 The South Antibody-drug Conjugates Status and Prospect (2012-2022)
1.4.7 The Midwest Antibody-drug Conjugates Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Antibody-drug Conjugates (2012-2022)
1.5.1 United States Antibody-drug Conjugates Sales and Growth Rate (2012-2022)
1.5.2 United States Antibody-drug Conjugates Revenue and Growth Rate (2012-2022)

2 United States Antibody-drug Conjugates Market Competition by Players/Suppliers
2.1 United States Antibody-drug Conjugates Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Antibody-drug Conjugates Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Antibody-drug Conjugates Average Price by Players/Suppliers (2012-2017)
2.4 United States Antibody-drug Conjugates Market Competitive Situation and Trends
2.4.1 United States Antibody-drug Conjugates Market Concentration Rate
2.4.2 United States Antibody-drug Conjugates Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Antibody-drug Conjugates Manufacturing Base Distribution, Sales Area, Product Type

3 United States Antibody-drug Conjugates Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Antibody-drug Conjugates Sales and Market Share by Region (2012-2017)
3.2 United States Antibody-drug Conjugates Revenue and Market Share by Region (2012-2017)
3.3 United States Antibody-drug Conjugates Price by Region (2012-2017)

4 United States Antibody-drug Conjugates Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Antibody-drug Conjugates Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Antibody-drug Conjugates Revenue and Market Share by Type (2012-2017)
4.3 United States Antibody-drug Conjugates Price by Type (2012-2017)
4.4 United States Antibody-drug Conjugates Sales Growth Rate by Type (2012-2017)

5 United States Antibody-drug Conjugates Sales (Volume) by Application (2012-2017)
5.1 United States Antibody-drug Conjugates Sales and Market Share by Application (2012-2017)
5.2 United States Antibody-drug Conjugates Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Antibody-drug Conjugates Players/Suppliers Profiles and Sales Data
6.1 F. Hoffmann-La Roche
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Antibody-drug Conjugates Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 F. Hoffmann-La Roche Antibody-drug Conjugates Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Seattle Genetics
6.2.2 Antibody-drug Conjugates Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Seattle Genetics Antibody-drug Conjugates Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Takeda Pharmaceuticals
6.3.2 Antibody-drug Conjugates Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Takeda Pharmaceuticals Antibody-drug Conjugates Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 AbbVie
6.4.2 Antibody-drug Conjugates Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 AbbVie Antibody-drug Conjugates Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 AbGenomics
6.5.2 Antibody-drug Conjugates Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 AbGenomics Antibody-drug Conjugates Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 ADC Therapeutics
6.6.2 Antibody-drug Conjugates Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 ADC Therapeutics Antibody-drug Conjugates Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Agensys
6.7.2 Antibody-drug Conjugates Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Agensys Antibody-drug Conjugates Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 ALMAC Group
6.8.2 Antibody-drug Conjugates Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 ALMAC Group Antibody-drug Conjugates Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Ambrx
6.9.2 Antibody-drug Conjugates Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Ambrx Antibody-drug Conjugates Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Astellas Pharma
6.10.2 Antibody-drug Conjugates Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Astellas Pharma Antibody-drug Conjugates Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview

7 Antibody-drug Conjugates Manufacturing Cost Analysis
7.1 Antibody-drug Conjugates Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Antibody-drug Conjugates

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Antibody-drug Conjugates Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Antibody-drug Conjugates Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Antibody-drug Conjugates Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Antibody-drug Conjugates Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Antibody-drug Conjugates Sales Volume Forecast by Type (2017-2022)
11.3 United States Antibody-drug Conjugates Sales Volume Forecast by Application (2017-2022)
11.4 United States Antibody-drug Conjugates Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer


List of Table

List of Tables and Figures

Figure Product Picture of Antibody-drug Conjugates
Figure United States Antibody-drug Conjugates Market Size (MT) by Type (2012-2022)
Figure United States Antibody-drug Conjugates Sales Volume Market Share by Type (Product Category) in 2016
Figure Seattle Genetics technology Product Picture
Figure ImmunoGen technology Product Picture
Figure Immunomedics technology Product Picture
Figure United States Antibody-drug Conjugates Market Size (MT) by Application (2012-2022)
Figure United States Sales Market Share of Antibody-drug Conjugates by Application in 2016
Figure IgG1 antibodies Examples
Figure HER2 antibodies Examples
Figure United States Antibody-drug Conjugates Market Size (Million USD) by Region (2012-2022)
Figure The West Antibody-drug Conjugates Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Antibody-drug Conjugates Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Antibody-drug Conjugates Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Antibody-drug Conjugates Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Antibody-drug Conjugates Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Antibody-drug Conjugates Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Antibody-drug Conjugates Sales (MT) and Growth Rate (2012-2022)
Figure United States Antibody-drug Conjugates Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Antibody-drug Conjugates Market Major Players Product Sales Volume (MT) (2012-2017)
Table United States Antibody-drug Conjugates Sales (MT) of Key Players/Suppliers (2012-2017)
Table United States Antibody-drug Conjugates Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Antibody-drug Conjugates Sales Share by Players/Suppliers
Figure 2017 United States Antibody-drug Conjugates Sales Share by Players/Suppliers
Figure United States Antibody-drug Conjugates Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Antibody-drug Conjugates Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Antibody-drug Conjugates Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Antibody-drug Conjugates Revenue Share by Players/Suppliers
Figure 2017 United States Antibody-drug Conjugates Revenue Share by Players/Suppliers
Table United States Market Antibody-drug Conjugates Average Price (USD/Kg) of Key Players/Suppliers (2012-2017)
Figure United States Market Antibody-drug Conjugates Average Price (USD/Kg) of Key Players/Suppliers in 2016
Figure United States Antibody-drug Conjugates Market Share of Top 3 Players/Suppliers
Figure United States Antibody-drug Conjugates Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Antibody-drug Conjugates Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Antibody-drug Conjugates Product Category
Table United States Antibody-drug Conjugates Sales (MT) by Region (2012-2017)
Table United States Antibody-drug Conjugates Sales Share by Region (2012-2017)
Figure United States Antibody-drug Conjugates Sales Share by Region (2012-2017)
Figure United States Antibody-drug Conjugates Sales Market Share by Region in 2016
Table United States Antibody-drug Conjugates Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Antibody-drug Conjugates Revenue Share by Region (2012-2017)
Figure United States Antibody-drug Conjugates Revenue Market Share by Region (2012-2017)
Figure United States Antibody-drug Conjugates Revenue Market Share by Region in 2016
Table United States Antibody-drug Conjugates Price (USD/Kg) by Region (2012-2017)
Table United States Antibody-drug Conjugates Sales (MT) by Type (2012-2017)
Table United States Antibody-drug Conjugates Sales Share by Type (2012-2017)
Figure United States Antibody-drug Conjugates Sales Share by Type (2012-2017)
Figure United States Antibody-drug Conjugates Sales Market Share by Type in 2016
Table United States Antibody-drug Conjugates Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Antibody-drug Conjugates Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Antibody-drug Conjugates by Type (2012-2017)
Figure Revenue Market Share of Antibody-drug Conjugates by Type in 2016
Table United States Antibody-drug Conjugates Price (USD/Kg) by Types (2012-2017)
Figure United States Antibody-drug Conjugates Sales Growth Rate by Type (2012-2017)
Table United States Antibody-drug Conjugates Sales (MT) by Application (2012-2017)
Table United States Antibody-drug Conjugates Sales Market Share by Application (2012-2017)
Figure United States Antibody-drug Conjugates Sales Market Share by Application (2012-2017)
Figure United States Antibody-drug Conjugates Sales Market Share by Application in 2016
Table United States Antibody-drug Conjugates Sales Growth Rate by Application (2012-2017)
Figure United States Antibody-drug Conjugates Sales Growth Rate by Application (2012-2017)
Table F. Hoffmann-La Roche Basic Information List
Table F. Hoffmann-La Roche Antibody-drug Conjugates Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure F. Hoffmann-La Roche Antibody-drug Conjugates Sales Growth Rate (2012-2017)
Figure F. Hoffmann-La Roche Antibody-drug Conjugates Sales Market Share in United States (2012-2017)
Figure F. Hoffmann-La Roche Antibody-drug Conjugates Revenue Market Share in United States (2012-2017)
Table Seattle Genetics Basic Information List
Table Seattle Genetics Antibody-drug Conjugates Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Seattle Genetics Antibody-drug Conjugates Sales Growth Rate (2012-2017)
Figure Seattle Genetics Antibody-drug Conjugates Sales Market Share in United States (2012-2017)
Figure Seattle Genetics Antibody-drug Conjugates Revenue Market Share in United States (2012-2017)
Table Takeda Pharmaceuticals Basic Information List
Table Takeda Pharmaceuticals Antibody-drug Conjugates Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Takeda Pharmaceuticals Antibody-drug Conjugates Sales Growth Rate (2012-2017)
Figure Takeda Pharmaceuticals Antibody-drug Conjugates Sales Market Share in United States (2012-2017)
Figure Takeda Pharmaceuticals Antibody-drug Conjugates Revenue Market Share in United States (2012-2017)
Table AbbVie Basic Information List
Table AbbVie Antibody-drug Conjugates Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure AbbVie Antibody-drug Conjugates Sales Growth Rate (2012-2017)
Figure AbbVie Antibody-drug Conjugates Sales Market Share in United States (2012-2017)
Figure AbbVie Antibody-drug Conjugates Revenue Market Share in United States (2012-2017)
Table AbGenomics Basic Information List
Table AbGenomics Antibody-drug Conjugates Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure AbGenomics Antibody-drug Conjugates Sales Growth Rate (2012-2017)
Figure AbGenomics Antibody-drug Conjugates Sales Market Share in United States (2012-2017)
Figure AbGenomics Antibody-drug Conjugates Revenue Market Share in United States (2012-2017)
Table ADC Therapeutics Basic Information List
Table ADC Therapeutics Antibody-drug Conjugates Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure ADC Therapeutics Antibody-drug Conjugates Sales Growth Rate (2012-2017)
Figure ADC Therapeutics Antibody-drug Conjugates Sales Market Share in United States (2012-2017)
Figure ADC Therapeutics Antibody-drug Conjugates Revenue Market Share in United States (2012-2017)
Table Agensys Basic Information List
Table Agensys Antibody-drug Conjugates Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Agensys Antibody-drug Conjugates Sales Growth Rate (2012-2017)
Figure Agensys Antibody-drug Conjugates Sales Market Share in United States (2012-2017)
Figure Agensys Antibody-drug Conjugates Revenue Market Share in United States (2012-2017)
Table ALMAC Group Basic Information List
Table ALMAC Group Antibody-drug Conjugates Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure ALMAC Group Antibody-drug Conjugates Sales Growth Rate (2012-2017)
Figure ALMAC Group Antibody-drug Conjugates Sales Market Share in United States (2012-2017)
Figure ALMAC Group Antibody-drug Conjugates Revenue Market Share in United States (2012-2017)
Table Ambrx Basic Information List
Table Ambrx Antibody-drug Conjugates Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Ambrx Antibody-drug Conjugates Sales Growth Rate (2012-2017)
Figure Ambrx Antibody-drug Conjugates Sales Market Share in United States (2012-2017)
Figure Ambrx Antibody-drug Conjugates Revenue Market Share in United States (2012-2017)
Table Astellas Pharma Basic Information List
Table Astellas Pharma Antibody-drug Conjugates Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Astellas Pharma Antibody-drug Conjugates Sales Growth Rate (2012-2017)
Figure Astellas Pharma Antibody-drug Conjugates Sales Market Share in United States (2012-2017)
Figure Astellas Pharma Antibody-drug Conjugates Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Antibody-drug Conjugates
Figure Manufacturing Process Analysis of Antibody-drug Conjugates
Figure Antibody-drug Conjugates Industrial Chain Analysis
Table Raw Materials Sources of Antibody-drug Conjugates Major Players/Suppliers in 2016
Table Major Buyers of Antibody-drug Conjugates
Table Distributors/Traders List
Figure United States Antibody-drug Conjugates Sales Volume (MT) and Growth Rate Forecast (2017-2022)
Figure United States Antibody-drug Conjugates Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Antibody-drug Conjugates Price (USD/Kg) Trend Forecast (2017-2022)
Table United States Antibody-drug Conjugates Sales Volume (MT) Forecast by Type (2017-2022)
Figure United States Antibody-drug Conjugates Sales Volume (MT) Forecast by Type (2017-2022)
Figure United States Antibody-drug Conjugates Sales Volume (MT) Forecast by Type in 2022
Table United States Antibody-drug Conjugates Sales Volume (MT) Forecast by Application (2017-2022)
Figure United States Antibody-drug Conjugates Sales Volume (MT) Forecast by Application (2017-2022)
Figure United States Antibody-drug Conjugates Sales Volume (MT) Forecast by Application in 2022
Table United States Antibody-drug Conjugates Sales Volume (MT) Forecast by Region (2017-2022)
Table United States Antibody-drug Conjugates Sales Volume Share Forecast by Region (2017-2022)
Figure United States Antibody-drug Conjugates Sales Volume Share Forecast by Region (2017-2022)
Figure United States Antibody-drug Conjugates Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *